Discovery of Disubstituted Imidazo[4,5-b]pyridines and Purines as Potent TrkA Inhibitors.
Saved in:
| Title: | Discovery of Disubstituted Imidazo[4,5-b]pyridines and Purines as Potent TrkA Inhibitors. |
|---|---|
| Authors: | Wang T; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Lamb ML; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Block MH; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Davies AM; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Han Y; Array BioPharma Inc. , 3200 Walnut Street, Boulder, Colorado 80301, United States., Hoffmann E; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Ioannidis S; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Josey JA; Array BioPharma Inc. , 3200 Walnut Street, Boulder, Colorado 80301, United States., Liu ZY; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Lyne PD; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., MacIntyre T; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Mohr PJ; Array BioPharma Inc. , 3200 Walnut Street, Boulder, Colorado 80301, United States., Omer CA; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Sjögren T; Discovery Sciences, Innovative Medicines, AstraZeneca , Pepparedsleden S431 83 Mölndal, Sweden., Thress K; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Wang B; Array BioPharma Inc. , 3200 Walnut Street, Boulder, Colorado 80301, United States., Wang H; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Yu D; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Zhang HJ; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States. |
| Source: | ACS medicinal chemistry letters [ACS Med Chem Lett] 2012 Jul 26; Vol. 3 (9), pp. 705-9. Date of Electronic Publication: 2012 Jul 26 (Print Publication: 2012). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 101521073 Publication Model: eCollection Cited Medium: Print ISSN: 1948-5875 (Print) Linking ISSN: 19485875 NLM ISO Abbreviation: ACS Med Chem Lett Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 24900538 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Discovery of Disubstituted Imidazo[4,5-b]pyridines and Purines as Potent TrkA Inhibitors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wang+T%22">Wang T</searchLink>; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Lamb+ML%22">Lamb ML</searchLink>; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Block+MH%22">Block MH</searchLink>; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Davies+AM%22">Davies AM</searchLink>; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Han+Y%22">Han Y</searchLink>; Array BioPharma Inc. , 3200 Walnut Street, Boulder, Colorado 80301, United States.<br /><searchLink fieldCode="AU" term="%22Hoffmann+E%22">Hoffmann E</searchLink>; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Ioannidis+S%22">Ioannidis S</searchLink>; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Josey+JA%22">Josey JA</searchLink>; Array BioPharma Inc. , 3200 Walnut Street, Boulder, Colorado 80301, United States.<br /><searchLink fieldCode="AU" term="%22Liu+ZY%22">Liu ZY</searchLink>; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Lyne+PD%22">Lyne PD</searchLink>; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22MacIntyre+T%22">MacIntyre T</searchLink>; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Mohr+PJ%22">Mohr PJ</searchLink>; Array BioPharma Inc. , 3200 Walnut Street, Boulder, Colorado 80301, United States.<br /><searchLink fieldCode="AU" term="%22Omer+CA%22">Omer CA</searchLink>; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Sjögren+T%22">Sjögren T</searchLink>; Discovery Sciences, Innovative Medicines, AstraZeneca , Pepparedsleden S431 83 Mölndal, Sweden.<br /><searchLink fieldCode="AU" term="%22Thress+K%22">Thress K</searchLink>; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Wang+B%22">Wang B</searchLink>; Array BioPharma Inc. , 3200 Walnut Street, Boulder, Colorado 80301, United States.<br /><searchLink fieldCode="AU" term="%22Wang+H%22">Wang H</searchLink>; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Yu+D%22">Yu D</searchLink>; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Zhang+HJ%22">Zhang HJ</searchLink>; Oncology Innovative Medicines Unit, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101521073%22">ACS medicinal chemistry letters</searchLink> [ACS Med Chem Lett] 2012 Jul 26; Vol. 3 (9), pp. 705-9. <i>Date of Electronic Publication: </i>2012 Jul 26 (<i>Print Publication: </i>2012). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101521073 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1948-5875 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219485875%22">19485875 </searchLink><i>NLM ISO Abbreviation: </i>ACS Med Chem Lett <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=24900538 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1021/ml300074j Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 705 Titles: – TitleFull: Discovery of Disubstituted Imidazo[4,5-b]pyridines and Purines as Potent TrkA Inhibitors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wang T – PersonEntity: Name: NameFull: Lamb ML – PersonEntity: Name: NameFull: Block MH – PersonEntity: Name: NameFull: Davies AM – PersonEntity: Name: NameFull: Han Y – PersonEntity: Name: NameFull: Hoffmann E – PersonEntity: Name: NameFull: Ioannidis S – PersonEntity: Name: NameFull: Josey JA – PersonEntity: Name: NameFull: Liu ZY – PersonEntity: Name: NameFull: Lyne PD – PersonEntity: Name: NameFull: MacIntyre T – PersonEntity: Name: NameFull: Mohr PJ – PersonEntity: Name: NameFull: Omer CA – PersonEntity: Name: NameFull: Sjögren T – PersonEntity: Name: NameFull: Thress K – PersonEntity: Name: NameFull: Wang B – PersonEntity: Name: NameFull: Wang H – PersonEntity: Name: NameFull: Yu D – PersonEntity: Name: NameFull: Zhang HJ IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 07 Text: 2012 Jul 26 Type: published Y: 2012 Identifiers: – Type: issn-print Value: 1948-5875 Numbering: – Type: volume Value: 3 – Type: issue Value: 9 Titles: – TitleFull: ACS medicinal chemistry letters Type: main |
| ResultId | 1 |